Bill Text: AZ HB2327 | 2013 | Fifty-first Legislature 1st Regular | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Dangerous drugs; definition.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Passed) 2013-04-03 - Governor Signed [HB2327 Detail]

Download: Arizona-2013-HB2327-Introduced.html

 

 

 

REFERENCE TITLE: dangerous drugs; definition.

 

 

 

 

State of Arizona

House of Representatives

Fifty-first Legislature

First Regular Session

2013

 

 

HB 2327

 

Introduced by

Representative Farnsworth

 

 

AN ACT

 

amending sections 13-3401, 32-1904 and 36-2512, Arizona Revised Statutes; relating to dangerous drugs.

 

 

(TEXT OF BILL BEGINS ON NEXT PAGE)

 



Be it enacted by the Legislature of the State of Arizona:

Section 1.  Section 13-3401, Arizona Revised Statutes, is amended to read:

START_STATUTE13-3401.  Definitions

In this chapter, unless the context otherwise requires:

1.  "Administer" means to apply, inject or facilitate the inhalation or ingestion of a substance to the body of a person.

2.  "Amidone" means any substance identified chemically as (4‑4‑diphenyl‑6‑dimethylamine‑heptanone‑3), or any salt of such substance, by whatever trade name designated.

3.  "Board" means the Arizona state board of pharmacy.

4.  "Cannabis" means the following substances under whatever names they may be designated:

(a)  The resin extracted from any part of a plant of the genus cannabis, and every compound, manufacture, salt, derivative, mixture or preparation of such plant, its seeds or its resin.  Cannabis does not include oil or cake made from the seeds of such plant, any fiber, compound, manufacture, salt, derivative, mixture or preparation of the mature stalks of such plant except the resin extracted from the stalks or any fiber, oil or cake or the sterilized seed of such plant which is incapable of germination.

(b)  Every compound, manufacture, salt, derivative, mixture or preparation of such resin or tetrahydrocannabinol.

5.  "Coca leaves" means cocaine, its optical isomers and any compound, manufacture, salt, derivative, mixture or preparation of coca leaves, except derivatives of coca leaves which do not contain cocaine, ecgonine or substances from which cocaine or ecgonine may be synthesized or made.

6.  "Dangerous drug" means the following by whatever official, common, usual, chemical or trade name designated:

(a)  Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances and their salts, isomers, whether optical, positional or geometric, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(i)  Alpha-ethyltryptamine.

(ii)  Aminorex.

(iii)  4-bromo-2, 5-dimethoxyphenethylamine.

(iv)  4‑bromo‑2, 5‑dimethoxyamphetamine.

(v)  Bufotenine.

(vi)  Diethyltryptamine.

(vii)  2, 5‑dimethoxyamphetamine.

(viii)  Dimethyltryptamine.

(ix)  5‑methoxy‑3, 4‑methylenedioxyamphetamine.

(x)  4‑methyl‑2, 5‑dimethoxyamphetamine.

(xi)  Ibogaine.

(xii)  Lysergic acid amide.

(xiii)  Lysergic acid diethylamide.

(xiv)  Mescaline.

(xv)  4-methoxyamphetamine.

(xvi)  Methoxymethylenedioxyamphetamine (MMDA).

(xvii)  Methylenedioxyamphetamine (MDA).

(xviii)  3, 4‑methylenedioxymethamphetamine.

(xix)  3, 4‑methylenedioxy‑N‑ethylamphetamine.

(xx)  N‑ethyl‑3‑piperidyl benzilate (JB‑318).

(xxi)  N‑hydroxy‑3, 4‑methylenedioxyamphetamine.

(xxii)  N‑methyl‑3‑piperidyl benzilate (JB‑336).

(xxiii)  N‑(1‑phenylcyclohexyl) ethylamine (PCE).

(xxiv)  Nabilone.

(xxv)  1‑(1‑phenylcyclohexyl) pyrrolidine (PHP).

(xxvi)  1‑(1‑(2‑thienyl)‑cyclohexyl) piperidine (TCP).

(xxvii)  1‑(1‑(2‑thienyl)‑cyclohexyl) pyrrolidine.

(xxviii)  Para‑methoxyamphetamine (PMA).

(xxix)  Psilocybin.

(xxx)  Psilocyn.

(xxxi)  Synhexyl.

(xxxii)  Trifluoromethylphenylpiperazine (TFMPP).

(xxxiii)  Trimethoxyamphetamine (TMA).

(xxxiv)  1-pentyl-3-(naphthoyl)indole (JWH-018 and isomers).

(xxxv)  1-butyl-3-(naphthoyl)indole (JWH-073 and isomers).

(xxxvi)  1-hexyl-3-(naphthoyl)indole (JWH-019 and isomers).

(xxxvii)  1-pentyl-3-(4-chloro naphthoyl)indole (JWH-398 and isomers).

(xxxviii)  1-(2-(4-(morpholinyl)ethyl))-3-(naphthoyl)indole (JWH-200 and isomers).

(xxxix)  1-pentyl-3-(methoxyphenylacetyl)indole (JWH-250 and isomers).

(xl)  (2-methyl-1-propyl-1H-indol-3-YL)-1-naphthalenyl-methanone (JWH‑015 and isomers).

(xli)  (6AR, 10AR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan2-YL)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol) (HU-210).

(xlii)  5-(1,1-dimethylheptyl)-2-(3-hydroxycyclohexyl)-phenol

(CP 47,497 and isomers).

(xliii)  5-(1,1-dimethyloctyl)-2-(3-hydroxycyclohexyl)-phenol

(cannabicyclohexanol, CP-47,497 C8 homologue and isomers).

(b)  Any material, compound, mixture or preparation which contains any quantity of cannabimimetic substances and their salts, isomers, whether optical, positional or geometric, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation.  For the purposes of this subdivision, "Cannabimimetic substances" means any substances within the following structural classes:

(i)  2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent.   Substances in the 2‑(3‑hydroxycyclohexyl)phenol generic definition include CP-47,497, CP‑47,497 C8-Homolog, CP-55,940 and CP-56,667.

(ii)  3-(naphthoyl)indole or 3-(naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.  Substances in the 3-(naphthoyl)indole generic definition include AM-678, AM-2201, JWH-004, JWH-007, JWH-009, JWH‑015, JWH-016, JWH-018, JWH-019, JWH-020, JWH-046, JWH-047, JWH-048, JWH‑049, JWH-050, JWH-070, JWH-071, JWH-072, JWH-073, JWH-076, JWH-079, JWH‑080, JWH-081, JWH-082, JWH-094, JWH-096, JWH-098, JWH-116, JWH-120, JWH‑122, JWH-148, JWH-149, JWH-175, JWH-180, JWH-181, JWH-182, JWH-184, JWH‑185, JWH-189, JWH-192, JWH-193, JWH-194, JWH-195, JWH-196, JWH-197, JWH‑199, JWH-200, JWH-210, JWH-211, JWH-212, JWH-213, JWH-234, JWH-235, JWH‑236, JWH-239, JWH-240, JWH-241, JWH-242, JWH-262, JWH-386, JWH-387, JWH‑394, JWH-395, JWH-397, JWH-398, JWH-399, JWH-400, JWH-412, JWH-413, JWH‑414 and JWH-415.

(iii)  3-(naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent. Substances in the 3-(naphthoyl)pyrrole generic definition include JWH-030, JWH-145, JWH-146, JWH-147, JWH-150, JWH-156, JWH-243, JWH-244, JWH-245, JWH‑246, JWH-292, JWH-293, JWH-307, JWH-308, JWH-346, JWH-348, JWH-363, JWH‑364, JWH-365, JWH-367, JWH-368, JWH-369, JWH-370, JWH-371, JWH-373 and JWH-392.

(iv)  1-(naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent. Substances in the 1-(naphthylmethylene)indene generic definition include JWH‑176.

(v)  3-(phenylacetyl)indole or 3-(benzoyl)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent. Substances in the 3-(phenylacetyl)indole generic definition include AM-694, AM‑2233, JWH-167, JWH-201, JWH-202, JWH-203, JWH-204, JWH‑205, JWH‑206, JWH‑207, JWH-208, JWH-209, JWH-237, JWH-248, JWH-250, JWH‑251, JWH‑253, JWH‑302, JWH-303, JWH-304, JWH-305, JWH-306, JWH-311, JWH‑312, JWH‑313, JWH‑314, JWH-315, JWH-316, RCS-4, RCS‑8, SR‑18 and SR‑19.

(vi)  3-(cyclopropylmethanone) indole or 3-(cyclobutylmethanone) indole or 3‑(cyclopentylmethanone) indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the cyclopropyl, cyclobutyl or cyclopentyl rings to any extent.   Substances in the 3‑(cyclopropylmethanone) indole generic definition include UR‑144, Fluoro‑UR‑144 and XLR‑11.

(b)  (c)  Any material, compound, mixture or preparation which contains any quantity of the following substances and their salts, optical isomers, whether optical, positional or geometric, and salts of optical isomers having a potential for abuse associated with a stimulant effect on the central nervous system:

(i)  Alpha-pyrrolidinobutiophenone (Alpha-PBP).

(ii)  Alpha-pyrrolidinopropiophenone (Alpha-PPP).

(iii)  Alpha-pyrrolidinovalerophenone (Alpha-PVP).

(i)  (iv)  Amphetamine.

(ii)  (v)  Benzphetamine.

(iii)  (vi)  Benzylpiperazine (BZP).

(vii)  Beta-keto-n‑methylbenzodioxolylbutanamine (Butylone).

(viii)  Beta-keto-n‑methylbenzodioxolylpentanamine (Pentylone).

(iv)  (ix Butorphanol.

(v)  Butylone.

(vi)  (x Cathine ((+)‑norpseudoephedrine).

(xi)  Cathinomimetic substances which are any substances derived from cathinone, (2-amino-1-phenyl-1-propanone) by any substitution at the phenyl ring, any substitution at the 3 position, any substitution at the nitrogen atom or any combination of the above substitutions.

(vii)  (xii)  Cathinone.

(xiii)  2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).

(viii)  (xiv)  Chlorphentermine.

(ix)  (xv)  Clortermine.

(x)  (xvi)  Diethylpropion.

(xvii)  Dihydro-5H-indeno-(5,6-d)-1,3-dioxol-6-amine) (MDAI).

(xviii)  2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).

(xix)  2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).

(xx)  2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).

(xxi)  2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).

(xxii)  2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).

(xxiii)  Dimethylcathinone (Metamfepramone).

(xxiv)  Ethcathinone.

(xxv)  2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2).

(xi)  (xxvi)  Fencamfamin.

(xii)  (xxvii)  Fenethylline.

(xiii)  (xxviii)  Fenproporex.

(xiv)  (xxix)  Fluoromethcathinone.

(xxx)  2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).

(xxxi)  2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4).

(xv)  (xxxii)  Mazindol.

(xvi)  (xxxiii)  Mefenorex.

(xvii)  (xxxiv)  Methamphetamine.

(xviii)  (xxxv)  Methcathinone.

(xxxvi)  Methoxy-alpha-pyrrolidinopropiophenone (MOPPP).

(xix)  (xxxvii)  Methoxymethcathinone (methedrone).

(xxxviii)  Methoxyphenethylamine mimetic substances which are any substances derived from 2, 5-dimethoxy-phenethylamine by any substitution at the phenyl ring, any substitution at the nitrogen atom or any combination of the above substitutions.

(xx)  (xxxix)  4‑methylaminorex.

(xl)  Methyl-a-pyrrolidinobutiophenone (MPBP).

(xli)  Methylenedioxy-alphapyrrolidinopropiophenone (MDPPP).

(xlii)  Methylenedioxyethcathinone (Ethylone). 

(xxi)  (xliii)  Methylenedioxymethcathinone (Methylone).

(xxii)  (xliv)  Methylenedioxypyrovalerone (MDPV).

(xxiii)  (xlv)  Methylmethcathinone (Mephedrone).

(xxiv)  (xlvi)  Methylphenidate.

(xxv)  (xlvii)  Modafinil.

(xxvi)  (xlviii)  Naphthylpyrovalerone (Naphyrone).

(xxvii)  (xlix)  N‑ethylamphetamine.

(xxviii)  (l)  N, N‑dimethylamphetamine.

(xxix)  (li)  Pemoline.

(xxx)  (lii)  Phendimetrazine.

(xxxi)  (liii)  Phenmetrazine.

(xxxii)  (liv)  Phentermine.

(xxxiii)  (lv)  Pipradol.

(xxxiv)  (lvi)  Propylhexedrine.

(xxxv)  (lvii)  Pyrovalerone.

(xxxvi)  (lviii)  Sibutramine.

(xxxvii)  (lix)  Spa ((-)‑1‑dimethylamino‑1,2‑diphenylethane).

(c)  (d)  Any material, compound, mixture or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:

(i)  Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, unless specifically excepted.

(ii)  Alprazolam.

(iii)  Bromazepam.

(iv)  Camazepam.

(v)  Carisoprodol.

(vi)  Chloral betaine.

(vii)  Chloral hydrate.

(viii)  Chlordiazepoxide.

(ix)  Chlorhexadol.

(x)  Clobazam.

(xi)  Clonazepam.

(xii)  Clorazepate.

(xiii)  Clotiazepam.

(xiv)  Cloxazolam.

(xv)  Delorazepam.

(xvi)  Diazepam.

(xvii)  Dichloralphenazone.

(xviii)  Estazolam.

(xix)  Ethchlorvynol.

(xx)  Ethinamate.

(xxi)  Ethyl loflazepate.

(xxii)  Fenfluramine.

(xxiii)  Fludiazepam.

(xxiv)  Flunitrazepam.

(xxv)  Flurazepam.

(xxvi)  Gamma hydroxy butyrate.

(xxvii)  Glutethimide.

(xxviii)  Halazepam.

(xxix)  Haloxazolam.

(xxx)  Ketamine.

(xxxi)  Ketazolam.

(xxxii)  Loprazolam.

(xxxiii)  Lorazepam.

(xxxiv)  Lormetazepam.

(xxxv)  Lysergic acid.

(xxxvi)  Mebutamate.

(xxxvii)  Mecloqualone.

(xxxviii)  Medazepam.

(xxxix)  Meprobamate.

(xl)  Methaqualone.

(xli)  Methohexital.

(xlii)  Methyprylon.

(xliii)  Midazolam.

(xliv)  Nimetazepam.

(xlv)  Nitrazepam.

(xlvi)  Nordiazepam.

(xlvii)  Oxazepam.

(xlviii)  Oxazolam.

(xlix)  Paraldehyde.

(l)  Petrichloral.

(li)  Phencyclidine.

(lii)  Pinazepam.

(liii)  Prazepam.

(liv)  Scopolamine.

(lv)  Sulfondiethylmethane.

(lvi)  Sulfonethylmethane.

(lvii)  Sulfonmethane.

(lviii)  Quazepam.

(lix)  Temazepam.

(lx)  Tetrazepam.

(lxi)  Tiletamine.

(lxii)  Triazolam.

(lxiii)  Zaleplon.

(lxiv)  Zolazepam.

(lxv)  Zolpidem.

(d)  (e)  Any material, compound, mixture or preparation which contains any quantity of the following anabolic steroids and their salts, isomers or esters:

(i)  Boldenone.

(ii)  Clostebol (4‑chlorotestosterone).

(iii)  Dehydrochloromethyltestosterone.

(iv)  Drostanolone.

(v)  Ethylestrenol.

(vi)  Fluoxymesterone.

(vii)  Formebulone (formebolone).

(viii)  Mesterolone.

(ix)  Methandriol.

(x)  Methandrostenolone (methandienone).

(xi)  Methenolone.

(xii)  Methyltestosterone.

(xiii)  Mibolerone.

(xiv)  Nandrolone.

(xv)  Norethandrolon.

(xvi)  Oxandrolone.

(xvii)  Oxymesterone.

(xviii)  Oxymetholone.

(xix)  Stanolone (4‑dihydrotestosterone).

(xx)  Stanozolol.

(xxi)  Testolactone.

(xxii)  Testosterone.

(xxiii)  Trenbolone.

7.  "Deliver" means the actual, constructive or attempted exchange from one person to another, whether or not there is an agency relationship.

8.  "Director" means the director of the department of health services.

9.  "Dispense" means distribute, leave with, give away, dispose of or deliver.

10.  "Drug court program" means a program that is established pursuant to section 13‑3422 by the presiding judge of the superior court in cooperation with the county attorney in a county for the purpose of prosecuting, adjudicating and treating drug dependent persons who meet the criteria and guidelines for entry into the program that are developed and agreed on by the presiding judge and the prosecutor.

11.  "Drug dependent person" means a person who is using a substance that is listed in paragraph 6, 19, 20, 21 or 28 of this section and who is in a state of psychological or physical dependence, or both, arising from the use of that substance.

12.  "Federal act" has the same meaning prescribed in section 32‑1901.

13.  "Isoamidone" means any substance identified chemically as (4‑4‑diphenyl‑5-methyl‑6-dimethylaminohexanone‑3), or any salt of such substance, by whatever trade name designated.

14.  "Isonipecaine" means any substance identified chemically as (1‑methyl‑4‑phenyl‑piperidine‑4‑carboxylic acid ethyl ester), or any salt of such substance, by whatever trade name designated.

15.  "Ketobemidone" means any substance identified chemically as (4‑(3‑hydroxyphenyl)‑1‑methyl‑4‑piperidylethyl ketone hydrochloride), or any salt of such substance, by whatever trade name designated.

16.  "Licensed" or "permitted" means authorized by the laws of this state to do certain things.

17.  "Manufacture" means produce, prepare, propagate, compound, mix or process, directly or indirectly, by extraction from substances of natural origin or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis.  Manufacture includes any packaging or repackaging or labeling or relabeling of containers.  Manufacture does not include any producing, preparing, propagating, compounding, mixing, processing, packaging or labeling done in conformity with applicable state and local laws and rules by a licensed practitioner incident to and in the course of his licensed practice.

18.  "Manufacturer" means a person who manufactures a narcotic or dangerous drug or other substance controlled by this chapter.

19.  "Marijuana" means all parts of any plant of the genus cannabis, from which the resin has not been extracted, whether growing or not, and the seeds of such plant.  Marijuana does not include the mature stalks of such plant or the sterilized seed of such plant which is incapable of germination.

20.  "Narcotic drugs" means the following, whether of natural or synthetic origin and any substance neither chemically nor physically distinguishable from them:

(a)  Acetyl‑alpha-methylfentanyl.

(b)  Acetylmethadol.

(c)  Alfentanil.

(d)  Allylprodine.

(e)  Alphacetylmethadol.

(f)  Alphameprodine.

(g)  Alphamethadol.

(h)  Alpha‑methylfentanyl.

(i)  Alpha‑methylthiofentanyl.

(j)  Alphaprodine.

(k)  Amidone (methadone).

(l)  Anileridine.

(m)  Benzethidine.

(n)  Benzylfentanyl.

(o)  Betacetylmethadol.

(p)  Beta‑hydroxyfentanyl.

(q)  Beta‑hydroxy‑3‑methylfentanyl.

(r)  Betameprodine.

(s)  Betamethadol.

(t)  Betaprodine.

(u)  Bezitramide.

(v)  Buprenorphine and its salts.

(w)  Cannabis.

(x)  Carfentanil.

(y)  Clonitazene.

(z)  Coca leaves.

(aa)  Dextromoramide.

(bb)  Dextropropoxyphene.

(cc)  Diampromide.

(dd)  Diethylthiambutene.

(ee)  Difenoxin.

(ff)  Dihydrocodeine.

(gg)  Dimenoxadol.

(hh)  Dimepheptanol.

(ii)  Dimethylthiambutene.

(jj)  Dioxaphetyl butyrate.

(kk)  Diphenoxylate.

(ll)  Dipipanone.

(mm)  Ethylmethylthiambutene.

(nn)  Etonitazene.

(oo)  Etoxeridine.

(pp)  Fentanyl.

(qq)  Furethidine.

(rr)  Hydroxypethidine.

(ss)  Isoamidone (isomethadone).

(tt)  Pethidine (meperidine).

(uu)  Ketobemidone.

(vv)  Levomethorphan.

(ww)  Levomoramide.

(xx)  Levophenacylmorphan.

(yy)  Levorphanol.

(zz)  Metazocine.

(aaa)  3‑methylfentanyl.

(bbb)  1‑methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP).

(ccc)  3‑methylthiofentanyl.

(ddd)  Morpheridine.

(eee)  Noracymethadol.

(fff)  Norlevorphanol.

(ggg)  Normethadone.

(hhh)  Norpipanone.

(iii)  Opium.

(jjj)  Para‑fluorofentanyl.

(kkk)  Pentazocine.

(lll)  Phenadoxone.

(mmm)  Phenampromide.

(nnn)  Phenazocine.

(ooo)  1‑(2‑phenethyl)‑4-phenyl‑4‑acetoxypiperidine (PEPAP).

(ppp)  Phenomorphan.

(qqq)  Phenoperidine.

(rrr)  Piminodine.

(sss)  Piritramide.

(ttt)  Proheptazine.

(uuu)  Properidine.

(vvv)  Propiram.

(www)  Racemethorphan.

(xxx)  Racemoramide.

(yyy)  Racemorphan.

(zzz)  Remifentanil.

(aaaa)  Sufentanil.

(bbbb)  Thenylfentanyl.

(cccc)  Thiofentanyl.

(dddd)  Tilidine.

(eeee)  Trimeperidine.

21.  "Opium" means any compound, manufacture, salt, isomer, salt of isomer, derivative, mixture or preparation of the following, but does not include apomorphine or any of its salts:

(a)  Acetorphine.

(b)  Acetyldihydrocodeine.

(c)  Benzylmorphine.

(d)  Codeine.

(e)  Codeine methylbromide.

(f)  Codeine‑N‑oxide.

(g)  Cyprenorphine.

(h)  Desomorphine.

(i)  Dihydromorphine.

(j)  Drotebanol.

(k)  Ethylmorphine.

(l)  Etorphine.

(m)  Heroin.

(n)  Hydrocodone.

(o)  Hydromorphinol.

(p)  Hydromorphone.

(q)  Levo-alphacetylmethadol.

(r)  Methyldesorphine.

(s)  Methyldihydromorphine.

(t)  Metopon.

(u)  Morphine.

(v)  Morphine methylbromide.

(w)  Morphine methylsulfonate.

(x)  Morphine‑N‑oxide.

(y)  Myrophine.

(z)  Nalorphine.

(aa)  Nicocodeine.

(bb)  Nicomorphine.

(cc)  Normorphine.

(dd)  Oxycodone.

(ee)  Oxymorphone.

(ff)  Pholcodine.

(gg)  Thebacon.

(hh)  Thebaine.

22.  "Ordinary ephedrine, pseudoephedrine, (-)‑norpseudoephedrine or phenylpropanolamine product" means a product that contains ephedrine, pseudoephedrine, (-)‑norpseudoephedrine or phenylpropanolamine and that is all of the following:

(a)  Approved for sale under the federal act.

(b)  Labeled, advertised and marketed only for an indication that is approved by the federal food and drug administration.

(c)  Either:

(i)  A nonliquid that is sold in package sizes of not more than three grams of ephedrine, pseudoephedrine, (-)‑norpseudoephedrine or phenlypropanolamine and that is packaged in blister packs containing not more than two dosage units or, if the use of blister packs is technically infeasible, that is packaged in unit dose packets or pouches.

(ii)  A liquid that is sold in package sizes of not more than three grams of ephedrine, pseudoephedrine, (-)‑norpseudoephedrine or phenylpropanolamine.

23.  "Peyote" means any part of a plant of the genus lophophora, known as the mescal button.

24.  "Pharmacy" means a licensed business where drugs are compounded or dispensed by a licensed pharmacist.

25.  "Practitioner" means a person licensed to prescribe and administer drugs.

26.  "Precursor chemical I" means any material, compound, mixture or preparation which contains any quantity of the following substances and their salts, optical isomers or salts of optical isomers:

(a)  N‑acetylanthranilic acid.

(b)  Anthranilic acid.

(c)  Ephedrine.

(d)  Ergotamine.

(e)  Isosafrole.

(f)  Lysergic acid.

(g)  Methylamine.

(h)  N‑ethylephedrine.

(i)  N‑ethylpseudoephedrine.

(j)  N‑methylephedrine.

(k)  N‑methylpseudoephedrine.

(l)  Norephedrine.

(m)  (-)‑Norpseudoephedrine.

(n)  Phenylacetic acid.

(o)  Phenylpropanolamine.

(p)  Piperidine.

(q)  Pseudoephedrine.

27.  "Precursor chemical II" means any material, compound, mixture or preparation which contains any quantity of the following substances and their salts, optical isomers or salts of optical isomers:

(a)  4‑cyano‑2‑dimethylamino-4, 4‑diphenyl butane.

(b)  4‑cyano-1‑methyl‑4‑phenylpiperidine.

(c)  Chlorephedrine.

(d)  Chlorpseudoephedrine.

(e)  Ethyl‑4‑phenylpiperidine‑4‑carboxylate.

(f)  2‑methyl‑3‑morpholino‑1, 1‑diphenylpropane‑carboxylic acid.

(g)  1‑methyl‑4‑phenylpiperidine‑4‑carboxylic acid.

(h)  N‑formyl amphetamine.

(i)  N‑formyl methamphetamine.

(j)  Phenyl‑2‑propanone.

(k)  1‑piperidinocyclohexane carbonitrile.

(l)  1‑pyrrolidinocyclohexane carbonitrile.

28.  "Prescription‑only drug" does not include a dangerous drug or narcotic drug but means:

(a)  Any drug which because of its toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use, is not generally recognized among experts, qualified by scientific training and experience to evaluate its safety and efficacy, as safe for use except by or under the supervision of a medical practitioner.

(b)  Any drug that is limited by an approved new drug application under the federal act or section 32‑1962 to use under the supervision of a medical practitioner.

(c)  Every potentially harmful drug, the labeling of which does not bear or contain full and adequate directions for use by the consumer.

(d)  Any drug required by the federal act to bear on its label the legend "Caution:  Federal law prohibits dispensing without prescription" or "Rx only".

29.  "Produce" means grow, plant, cultivate, harvest, dry, process or prepare for sale.

30.  "Regulated chemical" means the following substances in bulk form that are not a useful part of an otherwise lawful product:

(a)  Acetic anhydride.

(b)  Hypophosphorous acid.

(c)  Iodine.

(d)  Sodium acetate.

(e)  Red phosphorus.

(f)  Gamma butyrolactone (GBL).

(g)  1, 4‑butanediol.

(h)  Butyrolactone.

(i)  1, 2 butanolide.

(j)  2‑oxanalone.

(k)  Tetrahydro‑2‑furanone.

(l)  Dihydro‑2(3H)‑furanone.

(m)  Tetramethylene glycol.

31.  "Retailer" means either:

(a)  A person other than a practitioner who sells any precursor chemical or regulated chemical to another person for purposes of consumption and not resale, whether or not the person possesses a permit issued pursuant to title 32, chapter 18.

(b)  A person other than a manufacturer or wholesaler who purchases, receives or acquires more than twenty-four grams of a precursor chemical.

32.  "Sale" or "sell" means an exchange for anything of value or advantage, present or prospective.

33.  "Sale for personal use" means the retail sale for a legitimate medical use in a single transaction to an individual customer, to an employer for dispensing to employees from first aid kits or medicine chests or to a school for administration pursuant to section 15‑344.

34.  "Scientific purpose" means research, teaching or chemical analysis.

35.  "Suspicious transaction" means a transaction to which any of the following applies:

(a)  A report is required under the federal act.

(b)  The circumstances would lead a reasonable person to believe that any person is attempting to possess a precursor chemical or regulated chemical for the purpose of unlawful manufacture of a dangerous drug or narcotic drug, based on such factors as the amount involved, the method of payment, the method of delivery and any past dealings with any participant.

(c)  The transaction involves payment for precursor or regulated chemicals in cash or money orders in a total amount of more than two hundred dollars.

(d)  The transaction involves a sale, a transfer or furnishing to a retailer for resale without a prescription of ephedrine, pseudoephedrine, (‑)‑norpseudoephedrine or phenylpropanolamine that is not an ordinary ephedrine, pseudoephedrine, (-)‑norpseudoephedrine or phenylpropanolamine product.

36.  "Threshold amount" means a weight, market value or other form of measurement of an unlawful substance as follows:

(a)  One gram of heroin.

(b)  Nine grams of cocaine.

(c)  Seven hundred fifty milligrams of cocaine base or hydrolyzed cocaine.

(d)  Four grams or 50 milliliters of PCP.

(e)  Nine grams of methamphetamine, including methamphetamine in liquid suspension.

(f)  Nine grams of amphetamine, including amphetamine in liquid suspension.

(g)  One‑half milliliter of lysergic acid diethylamide, or in the case of blotter dosage units fifty dosage units.

(h)  Two pounds of marijuana.

(i)  For any combination consisting solely of those unlawful substances listed in subdivisions (a) through (h) of this paragraph, an amount equal to or in excess of the threshold amount, as determined by the application of section 13‑3420.

(j)  For any unlawful substance not listed in subdivisions (a) through (h) of this paragraph or any combination involving any unlawful substance not listed in subdivisions (a) through (h) of this paragraph, a value of at least one thousand dollars.

37.  "Transfer" means furnish, deliver or give away.

38.  "Vapor‑releasing substance containing a toxic substance" means a material which releases vapors or fumes containing any of the following:

(a)  Ketones, including acetone, methyl ethyl ketone, mibk, miak, isophorone and mesityl oxide. 

(b)  Hydrocarbons, including propane, butane, pentane, hexane, heptane and halogenated hydrocarbons.

(c)  Ethylene dichloride.

(d)  Pentachlorophenol.

(e)  Chloroform.

(f)  Methylene chloride.

(g)  Trichloroethylene.

(h)  Difluoroethane.

(i)  Tetrafluoroethane.

(j)  Aldehydes, including formaldehyde.

(k)  Acetates, including ethyl acetate and butyl acetate.

(l)  Aromatics, including benzene, toluene, xylene, ethylbenzene and cumene.

(m)  Alcohols, including methyl alcohol, ethyl alcohol, isopropyl alcohol, butyl alcohol and diacetone alcohol.

(n)  Ether, including Diethyl ether and petroleum ether.

(o)  Nitrous oxide.

(p)  Amyl nitrite.

(q)  Isobutyl nitrite.

39.  "Weight" unless otherwise specified includes the entire weight of any mixture or substance that contains a detectable amount of an unlawful substance.  If a mixture or substance contains more than one unlawful substance, the weight of the entire mixture or substance is assigned to the unlawful substance that results in the greater offense.  If a mixture or substance contains lysergic acid diethylamide, the offense that results from the unlawful substance shall be based on the greater offense as determined by the entire weight of the mixture or substance or the number of blotter dosage units.  For the purposes of this paragraph, "mixture" means any combination of substances from which the unlawful substance cannot be removed without a chemical process.

40.  "Wholesaler" means a person who in the usual course of business lawfully supplies narcotic drugs, dangerous drugs, precursor chemicals or regulated chemicals that he himself has not produced or prepared, but not to a person for the purpose of consumption by the person, whether or not the wholesaler has a permit that is issued pursuant to title 32, chapter 18. Wholesaler includes a person who sells, delivers or dispenses a precursor chemical in an amount or under circumstances that would require registration as a distributor of precursor chemicals under the federal act. END_STATUTE

Sec. 2.  Section 32-1904, Arizona Revised Statutes, is amended to read:

START_STATUTE32-1904.  Powers and duties of board; immunity

A.  The board shall:

1.  Make bylaws and adopt rules that are necessary for the protection of the public and that pertain to the practice of pharmacy, the manufacturing, wholesaling or supplying of drugs, devices, poisons or hazardous substances, the use of pharmacy technicians and support personnel and the lawful performance of its duties.

2.  Fix standards and requirements for the registration and reregistration of pharmacies, except as otherwise specified.

3.  Investigate compliance as to the quality, label and labeling of all drugs, devices, poisons or hazardous substances and take action necessary to prevent the sale of these if they do not conform to the standards prescribed in this chapter, the official compendium or the federal act.

4.  Enforce its rules.  In so doing, the board or its agents have free access at all reasonable hours to any pharmacy, manufacturer, wholesaler, nonprescription drug permittee or other establishment in which drugs, devices, poisons or hazardous substances are manufactured, processed, packed or held, or to enter any vehicle being used to transport or hold such drugs, devices, poisons or hazardous substances for the purpose of:

(a)  Of Inspecting the establishment or vehicle to determine if any provisions of this chapter or the federal act are being violated.

(b)  Of Securing samples or specimens of any drug, device, poison or hazardous substance after paying or offering to pay for such sample.

(c)  Of Detaining or embargoing a drug, device, poison or hazardous substance in accordance with section 32‑1994.

5.  Examine and license as pharmacists and pharmacy interns all qualified applicants as provided by this chapter.

6.  Issue duplicates of lost or destroyed permits on the payment of a fee as prescribed by the board.

7.  Adopt rules for the rehabilitation of pharmacists and pharmacy interns as provided by this chapter.

8.  At least once every three months, notify pharmacies regulated pursuant to this chapter of any modifications on prescription writing privileges of podiatrists, dentists, doctors of medicine, registered nurse practitioners, osteopathic physicians, veterinarians, physician assistants, optometrists and homeopathic physicians of which it receives notification from the board of podiatry examiners, board of dental examiners, Arizona medical board, board of nursing, board of osteopathic examiners in medicine and surgery, veterinary medical examining board, Arizona regulatory board of physician assistants, board of optometry or board of homeopathic and integrated medicine examiners.

B.  The board may:

1.  Employ chemists, compliance officers, clerical help and other employees subject to title 41, chapter 4, article 4 and provide laboratory facilities for the proper conduct of its business.

2.  Provide, by education of and information to the licensees and to the public, assistance in the curtailment of abuse in the use of drugs, devices, poisons and hazardous substances.

3.  Approve or reject the manner of storage and security of drugs, devices, poisons and hazardous substances.

4.  Accept monies and services to assist in the enforcement of this chapter from other than licensees:

(a)  For performing inspections and other board functions.

(b)  For the cost of copies of the pharmacy and controlled substances laws, the annual report of the board and other information from the board.

5.  Adopt rules for professional conduct appropriate to the establishment and maintenance of a high standard of integrity and dignity in the profession of pharmacy.

6.  Grant permission to deviate from a state requirement for experimentation and technological advances.

7.  Adopt rules for the training and practice of pharmacy interns, pharmacy technicians and support personnel.

8.  Investigate alleged violations of this chapter, conduct hearings in respect to violations, subpoena witnesses and take such action as it deems necessary to revoke or suspend a license or a permit, place a licensee or permittee on probation or warn a licensee or permittee under this chapter or to bring notice of violations to the county attorney of the county in which a violation took place or to the attorney general.

9.  By rule, approve colleges or schools of pharmacy.

10.  By rule, approve programs of practical experience, clinical programs, internship training programs, programs of remedial academic work and preliminary equivalency examinations as provided by this chapter.

11.  Assist in the continuing education of pharmacists and pharmacy interns.

12.  Issue inactive status licenses as provided by this chapter.

13.  Accept monies and services from the federal government or others for educational, research or other purposes pertaining to the enforcement of this chapter.

14.  By rule, except from the application of all or any part of this chapter any material, compound, mixture or preparation containing any stimulant or depressant substance included in section 13‑3401, paragraph 6, subdivision (b) or (c) or (d) from the definition of dangerous drug if the material, compound, mixture or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, provided that such admixtures are included in such combinations, quantity, proportion or concentration as to vitiate the potential for abuse of the substances that do have a stimulant or depressant effect on the central nervous system.

15.  Adopt rules for the revocation, suspension or reinstatement of licenses or permits or the probation of licensees or permittees as provided by this chapter.

C.  The executive director and other personnel or agents of the board are not subject to civil liability for any act done or proceeding undertaken or performed in good faith and in furtherance of the purposes of this chapter. END_STATUTE

Sec. 3.  Section 36-2512, Arizona Revised Statutes, is amended to read:

START_STATUTE36‑2512.  Substances in schedule I

A.  The following controlled substances, unless specifically excepted, are included in schedule I:

1.  Any of the following, including opiates and their isomers, esters, ethers, salts and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:

(a)  Acetyl‑alpha‑methylfentanyl.

(b)  Allylprodine.

(c)  Alpha‑methylthiofentanyl.

(d)  Alphacetylmethadol.

(e)  Alphameprodine.

(f)  Alphamethadol.

(g)  Alpha‑methylfentanyl.

(h)  Benzethidine.

(i)  Benzylfentanyl and its optical isomers, salts and salts of isomers.

(j)  Beta‑hydroxyfentanyl.

(k)  Beta‑hydroxy‑3‑methylfentanyl.

(l)  Betacetylmethadol.

(m)  Betameprodine.

(n)  Betamethadol.

(o)  Betaprodine.

(p)  Clonitazene.

(q)  Dextromoramide.

(r)  Diampromide.

(s)  Diethylthiambutene.

(t)  Difenoxin.

(u)  Dimenoxadol.

(v)  Dimepheptanol.

(w)  Dimethylthiambutene.

(x)  Dioxaphetyl butyrate.

(y)  Dipipanone.

(z)  Ethylmethylthiambutene.

(aa)  Etonitazene.

(bb)  Etoxeridine.

(cc)  4‑methylaminorex.

(dd)  Furethidine.

(ee)  Hydroxypethidine.

(ff)  Ketobemidone.

(gg)  Levomoramide.

(hh)  Levophenacylmorphan.

(ii)  MPPP (1‑methyl‑4‑phenyl‑4‑propionoxypiperidine).

(jj)  Morpheridine.

(kk)  Noracymethadol.

(ll)  Norlevorphanol.

(mm)  Normethadone.

(nn)  Norpipanone.

(oo)  Para‑fluorofentanyl.

(pp)  Pepap (1‑(2‑phenethyl)‑4‑phenyl‑4‑acetoxypiperidine).

(qq)  Phenadoxone.

(rr)  Phenampromide.

(ss)  Phenomorphan.

(tt)  Phenoperidine.

(uu)  Piritramide.

(vv)  Proheptazine.

(ww)  Properidine.

(xx)  Propiram.

(yy)  Racemoramide.

(zz)  Thenylfentanyl and its optical isomers, salts and salts of isomers.

(aaa)  Thiofentanyl.

(bbb)  3‑methylfentanyl.

(ccc)  3‑methylthiofentanyl.

(ddd)  Tilidine.

(eee)  Trimeperidine.

2.  Any of the following opium derivatives and their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(a)  Acetorphine.

(b)  Acetyldihydrocodeine.

(c)  Benzylmorphine.

(d)  Codeine methylbromide.

(e)  Codeine‑n‑oxide.

(f)  Cyprenorphine.

(g)  Desomorphine.

(h)  Dihydromorphine.

(i)  Drotebanol.

(j)  Etorphine, except hydrochloride salt.

(k)  Heroin.

(l)  Hydromorphinol.

(m)  Methyldesorphine.

(n)  Methyldihydromorphine.

(o)  Morphine methylbromide.

(p)  Morphine methylsulfonate.

(q)  Morphine‑n‑oxide.

(r)  Myrophine.

(s)  Nicocodeine.

(t)  Nicomorphine.

(u)  Normorphine.

(v)  Pholcodeine.

(w)  Thebacon.

3.  Any material, compound, mixture or preparation that contains any quantity of the following hallucinogenic substances and their salts, isomers and salts of isomers, unless specifically excepted or unless listed in another schedule, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation (for the purposes of this paragraph, "isomer" includes the optical, position and geometric isomers):

(a)  4‑bromo‑2, 5‑dimethoxyamphetamine.

(b)  2, 5‑dimethoxyamphetamine.

(c)  4‑methoxyamphetamine.

(d)  5‑methoxy‑3, 4‑methylenedioxyamphetamine.

(e)  4‑methyl‑2, 5‑dimethoxyamphetamine.

(f)  3, 4‑methylenedioxymethamphetamine (MDMA).

(g)  3, 4‑methylenedioxy amphetamine.

(h)  3, 4, 5‑trimethoxy amphetamine.

(i)  alpha‑ethyltryptamine.

(j)  Bufotenine.

(k)  Diethyltryptamine.

(l)  Dimethyltryptamine.

(m)  Ibogaine.

(n)  Lysergic acid diethylamide.

(o)  Cannabis, except the synthetic isomer of delta‑9‑tetraydrocannabinol.

(p)  Mescaline.

(q)  Parahexyl.

(r)  Peyote.

(s)  N‑ethyl‑3‑piperidyl benzilate.

(t)  N‑methyl‑3‑piperidyl benzilate.

(u)  N‑hydroxy‑3,4‑methylenedioxyamphetamine.

(v)  N,N‑Dimethylamphetamine.

(w)  3, 4‑methylenedioxy‑n‑ethylamphetamine.

(x)  Psilocybin.

(y)  Psilocyn.

(z)  Ethylamine analog of phencyclidine.

(aa)  Pyrrolidine analog of phencyclidine.

(bb)  1‑(1‑(2‑thienyl)cyclohexyl)pyrrolidine.

(cc)  Thiophene analog of phencyclidine.

(dd)  Aminorex.

(ee)  4‑bromo‑2,5‑dimethoxyphenethylamine.

(ff)  1-pentyl-3-(naphthoyl)indole (JWH-018 and isomers).

(gg)  1-butyl-3-(naphthoyl)indole (JWH-073 and isomers).

(hh)  1-hexyl-3-(naphthoyl)indole (JWH-019 and isomers).

(ii)  1-pentyl-3-(4-chloro naphthoyl)indole (JWH-398 and isomers).

(jj)  1-(2-(4-(morpholinyl)ethyl))-3-(naphthoyl)indole (JWH-200 and isomers).

(kk)  1-pentyl-3-(methoxyphenylacetyl)indole (JWH-250 and isomers).

(ll)  (2-methyl-1-propyl-1h-indol-3-yl)-1-naphthalenyl-methanone (JWH‑015 and isomers).

(mm)  (6ar,10ar)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol) (hu-210).

(nn)  5-(1,1-dimethylheptyl)-2-(3-hydroxycyclohexyl)-phenol (cp 47,497 and isomers).

(oo)  5-(1,1-dimethyloctyl)-2-(3-hydroxycyclohexyl)-phenol (cannabicyclohexanol, cp-47,497 c8 homologue and isomers).

(pp)  Any material, compound, mixture or preparation which contains any quantity of cannabimimetic substances and their salts, isomers, whether optical, positional or geometric, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation.  For the purposes of this subdivision, "Cannabimimetic substances" means any substances within the following structural classes:

(i)  2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent. Substances in the 2‑(3‑hydroxycyclohexyl)phenol generic definition include CP-47,497, CP‑47,497 C8‑Homolog, CP-55,940 and CP-56,667.

(ii)  3-(naphthoyl)indole or 3-(naphthylmethane)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent.  Substances in the 3-(naphthoyl)indole generic definition include AM-678, AM-2201, JWH-004, JWH-007, JWH-009, JWH‑015, JWH-016, JWH-018, JWH-019, JWH-020, JWH-046, JWH-047, JWH-048, JWH‑049, JWH-050, JWH-070, JWH-071, JWH-072, JWH-073, JWH-076, JWH-079, JWH‑080, JWH-081, JWH-082, JWH-094, JWH-096, JWH-098, JWH-116, JWH-120, JWH‑122, JWH-148, JWH-149, JWH-175, JWH-180, JWH-181, JWH-182, JWH-184, JWH‑185, JWH-189, JWH-192, JWH-193, JWH-194, JWH-195, JWH-196, JWH-197, JWH‑199, JWH-200, JWH-210, JWH-211, JWH-212, JWH-213, JWH-234, JWH-235, JWH‑236, JWH-239, JWH-240, JWH-241, JWH-242, JWH-262, JWH-386, JWH-387, JWH‑394, JWH-395, JWH-397, JWH-398, JWH-399, JWH-400, JWH-412, JWH-413, JWH‑414 and JWH-415.

(iii)  3-(naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent. Substances in the 3-(naphthoyl)pyrrole generic definition include JWH-030, JWH-145, JWH-146, JWH-147, JWH-150, JWH-156, JWH-243, JWH-244, JWH-245, JWH‑246, JWH-292, JWH-293, JWH-307, JWH-308, JWH-346, JWH-348, JWH-363, JWH‑364, JWH-365, JWH-367, JWH-368, JWH-369, JWH-370, JWH-371, JWH-373 and JWH-392.

(iv)  1-(naphthylmethylene)indene by substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent. Substances in the 1-(naphthylmethylene)indene generic definition include JWH‑176.

(v)  3-(phenylacetyl)indole or 3-(benzoyl)indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent. Substances in the 3-(phenylacetyl)indole generic definition include AM-694, AM‑2233, JWH-167, JWH-201, JWH-202, JWH-203, JWH-204, JWH‑205, JWH‑206, JWH‑207, JWH-208, JWH-209, JWH-237, JWH-248, JWH-250, JWH‑251, JWH‑253, JWH‑302, JWH-303, JWH-304, JWH-305, JWH-306, JWH-311, JWH‑312, JWH‑313, JWH‑314, JWH-315, JWH-316, RCS-4, RCS-8, SR‑18 and SR‑19.

(vi)  3-(cyclopropylmethanone) indole or 3-(cyclobutylmethanone) indole or 3‑(cyclopentylmethanone) indole by substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the cyclopropyl, cyclobutyl or cyclopentyl rings to any extent.   Substances in the 3‑(cyclopropylmethanone) indole generic definition include UR‑144, Fluoro‑UR‑144 and XLR‑11.

4.  Any of the following substances having a depressant effect on the central nervous system, including their salts, isomers and salts of isomers, unless specifically excepted or listed in another schedule, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(a)  Mecloqualone.

(b)  Methaqualone.

5.  Gamma‑hydroxybutyric acid, any salt, hydroxybutyric compound, derivative or preparation of gamma‑hydroxybutyric acid, including any isomers, esters and ethers and salts of isomers, esters and ethers of gamma‑hydroxybutyric acid, except gamma‑butyrolactone if the existence of the isomers, esters and salts is possible within the specific chemical designation.  Notwithstanding any other provision of the federal food, drug and cosmetic act, for purposes of security requirements imposed by law or regulation on registered distributors and registered manufacturers, this substance if manufactured, distributed or processed in accordance with an exemption approved under section 505 of the federal food, drug and cosmetic act is a controlled substance in schedule III pursuant to section 36‑2514.

6.  Any of the following stimulants including their salts, isomers and salts of isomers, unless specifically excepted or listed in another schedule, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(a)  Alpha-pyrrolidinobutiophenone (Alpha-PBP).

(b)  Alpha-pyrrolidinopropiophenone (Alpha-PPP).

(c)  Alpha-pyrrolidinovalerophenone (Alpha-PVP).

(d)  Beta-keto-n‑methylbenzodioxolylbutanamine (Butylone).

(e)  Beta-keto-n‑methylbenzodioxolylpentanamine (Pentylone).

(f)  Cathinomimetic substances which are any substances derived from cathinone, (2-amino-1-phenyl-1-propanone) by any substitution at the phenyl ring, any substitution at the 3 position, any substitution at the nitrogen atom or any combination of the above substitutions.

(g)  2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C).

(h)  (+)cis‑4‑methylaminorex((+)cis‑4,5‑dihydro‑4‑methyl‑5‑phenyl-2-oxazolamine).

(i)  Dihydro-5H-indeno-(5,6-d)-1,3-dioxol-6-amine) (MDAI).

(j)  2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).

(k)  2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).

(l)  2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N).

(m)  2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).

(n)  2-(2,5-Dimethoxyphenyl)ethanamine (2C-H).

(o)  Dimethylcathinone (Metamfepramone).

(p)  Ethcathinone.

(q)  2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2).

(a)  Methcathinone.

(b)  (r)  Fenethylline.

(s)  2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I).

(t)  2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4).

(u)  Methcathinone.

(v)  Methoxy-alpha-pyrrolidinopropiophenone (MOPPP).

(w)  Methoxyphenethylamine mimetic substances which are any substances derived from 2, 5-dimethoxy-phenethylamine by any substitution at the phenyl ring, any substitution at the nitrogen atom or any combination of the above substitutions.

(x)  Methyl-a-pyrrolidinobutiophenone (MPBP).

(y)  Methylenedioxy-alphapyrrolidinopropiophenone (MDPPP).

(z)  Methylenedioxyethcathinone (Ethylone).

(c)  (aa)  N‑ethylamphetamine.

(d)  (+)cis‑4‑methylaminorex((+)cis‑4,5‑dihydro‑4‑methyl‑5‑phenyl-2-oxazolamine).

B.  The board may except by rule any compound, mixture or preparation containing any substance listed in this section from the application of all or any part of this chapter if the compound, mixture or preparation contains one or more active medicinal ingredients and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiates the potential for abuse. END_STATUTE

feedback